New sickle cell treatment sparks feelings of hope and some hesitancy among Black patients

The Food and Drug Administration must decide by Friday whether to approve a new gene-editing therapy to treat sickle cell disease, a debilitating blood disorder that affects at least 100,000 Americans, most of whom are Black. The treatment, called exa-cel, would be the first approved medicine in…#crisprtherapeutics #derekrobertson #ceceliacalhoun #smilowcancerhospital #connecticut #kaylasmithowens #chesapeakebeach #maryland #bowiestateuniversity #smithowens
Source: Reuters: Health - Category: Consumer Health News Source Type: news